New drug tested for Long-Term schizophrenia management
NCT ID NCT01625897
Summary
This study tested the long-term safety and effectiveness of an investigational medication called MP-214 for people with chronic schizophrenia, including elderly patients. It involved 125 participants and aimed to see how well the drug worked and was tolerated over an extended period. The goal was to gather data to support its use as a long-term treatment option.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Study site
Aizu-Wakamatsu, Fukushima, Japan
Conditions
Explore the condition pages connected to this study.